Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2021-10-08 00:00:00 ET · period of report 2021-10-07 · accession 0001209191-21-060035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-08 | 2021-10-07 | TVTX | ASELAGE STEVE | Dir | S - Sale+OE | $26.25 | -60.0K | 189.8K | -24% | -$1.57M |
| D | 2021-10-08 | 2021-10-07 | TVTX | ASELAGE STEVE | Dir | M - OptEx | $16.23 | +60.0K | 249.8K | +32% | +$973.8K |
| D | 2021-10-08 | 2021-10-07 | TVTX | ASELAGE STEVE | Dir | M - OptEx | $0.00 | -60.0K | 80.0K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-07 | S | D | 28,000 | $26.23 | 221,794 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-07 | M | A | 60,000 | $16.23 | 249,794 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-07 | S | D | 32,000 | $26.26 | 189,794 | D | — | — | |
| 4 | Derivative | Employee stock option (right to buy) | 2021-10-07 | M | D | 60,000 | $0.00 | 80,000 | D | $16.23 · — to 2026-05-18 | 60,000 Common Stock | (F2) The stock option is fully vested and exercisable. |